Catalyst Wire Dossier Catalyst Wire Dossier

RoActemra/Actemra

tocilizumab · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

61 regulatory and trial events tracked for RoActemra/Actemra, covering 2011-10-26 to 2018-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

See pricing